Which medication is specifically indicated for Type 2 diabetes and is administered twice daily?

The answer is Byetta, which is an injectable medication specifically indicated for the management of Type 2 diabetes. It belongs to a class of medications known as GLP-1 receptor agonists, which help lower blood glucose levels by stimulating insulin secretion in response to meals, inhibiting glucagon secretion, and promoting satiety.

Byetta is given twice daily, typically before meals, which allows for more immediate control over postprandial blood sugar levels. This timing aligns with the pharmacokinetics of the drug, providing effective management of glycemic control throughout the day.

In contrast, Bydureon is an extended-release formulation of Byetta that is administered once weekly, and Victoza is another GLP-1 receptor agonist that is given once daily. Saxenda, while similar to Victoza, is primarily indicated for weight management rather than diabetes.